FindTrial
Sign In

A study to know whether we can supervise cancer patients infected with COVID-19 from without admission in hospitals. We will test how much helpful is a software called Datos health along with pulse oximeter and thermometer in this supervision by doctors.

To test the feasibility of a novel machine-learned triage software, Datos in conjunction with pulse oximeter and temperature device for remote screening, monitoring, and triage of oncology patients infected with COVID-19.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028256
Enrollment
30
Registered
2020-10-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Datos Platform in conjunction with thermometer and pulse oximeter.: Datos platform is a phone application available in public domain. The platform will be utilized to integrate readings

Sponsors

Tata Memorial Hospital Research Administrative Council
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Male or Female adults age greater than or equal to 18 years old. 2. All Patients must have an oncologic diagnosis. 3. Patients must be positive for COVID-19 and require outpatient monitoring. 4. ECOG greater than or equal to 2. 5. Able to sign informed consent and to comply with protocol. 6. Patients must be comfortable with using the pulse oximeter and thermometer device as well as be able to follow basic instructions for the device in the opinion of the study team.

Exclusion criteria

Exclusion criteria: 1. Clinical illness requiring hospitalization. 2. Unable to consent, use and follow the study device instructions for the entire study period. 3. Substance and/or alcohol abuse

Design outcomes

Primary

MeasureTime frame
a) Proportion of patients recording data in a continuous manner using Datos Platform b) Patient experience using a validated Usefulness, Satisfaction, and Ease of use (USE) Questionnaire to assess compliance and user/patient experience.Timepoint: a) After 24 hour or at the end of completion of study (between 1 to 4 week).—

Secondary

MeasureTime frame
Tele-medicine session, outpatient checkup appointments or inpatient admissions for clinical deterioration) with the help of Datos platform. Timepoint: After 24 hour or on before 30 days.—

Countries

India

Contacts

Public ContactDr Manju Sengar

Tata Memorial Centre

manju.sengar@gmail.com02224177211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026